Showing results (531-540 of 1,091) with videos related to

Sort By:
Pageof 110
Blood|July 1, 1986
A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF)P M Mannucci, R Lombardi, A B Federici, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1979
Familial incidence of precipitating antibodies in von Willebrand's disease: a study of four casesZ M Ruggeri, N Ciavarella, P M Mannucci, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2012
Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patientsG Castaman, A B Federici, A Tosetto, et al.
Blood|August 1, 1993
Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization methodA Inbal, T Englender, N Kornbrot, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 3, 2013
Orthopaedic surgery in patients with von Willebrand diseaseS M Siboni, E Biguzzi, L P Solimeno, et al.
Transfusion|May 1, 1997
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilizationE Santagostino, P M Mannucci, A Gringeri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 9, 2009
Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease: results of an Italian cohort study on 120 patients characterized by bleeding severity scoreA B Federici, G Barillari, E Zanon, et al.
British Journal of Haematology|August 1, 1993
Markers of procoagulant imbalance in patients with localized melanomas and autoimmune disordersA Tripodi, P M Mannucci, V Chantarangkul, et al.
Blood|August 15, 1994
Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patientsP M Mannucci, K A Bauer, E Santagostino, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 1997
A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506)M Cattaneo, M Y Tsai, P Bucciarelli, et al.
Pageof 110